Save the animals from dying in labs… first auto-culture device from MEPSGEN
2023-11-27
MEPSGEN is attending the 2023 Korean BioChip Society Fall Conference in Jeju, November 15-17.
2023-11-14
Korea-Japan Pharma-Bio Exchange Boosted by Behind the Scenes Efforts
2023-10-16
[BIO JAPAN 2023] MEPSGEN's participation in BIO JAPAN
2023-10-06
“신약개발, 똑똑하게 뭉치자” 연합전선 새 판 짜는 K제약바이오
2023-09-26
MEPSGEN plans to IPO in 2025
2023-09-25
MEPS-AMS is the answer to the rapid advancement of MPS
MEPSGEN's expertise in both MPS and nanoparticle technologies
Korea should kick off national-level project to end animal-testing
2023-09-19
South Korea's national assembly must pass the VAAM act to become a first mover
2023-09-18
MEPSGEN's MPS chip will lead the global drug evaluation platform market
2023-09-08
To network with amazing people at KAATC
2023-09-07
Which non-clinical platform will fill the gap?
2023-08-09
CEO YongTae Kim shares his thoughts on how blood-brain-barrier-on-a-chip could improve the drug development process
2023-08-02
Mepsgen targets CRO business with its scalable microphysiological system solution
2023-07-18
[BIOPLUS-INTERPHEX (BIX) KOREA 2023] Mepsgen attends BIX
2023-07-11
New Research Paper titled "Manufactured Tissue-to-Tissue Barrier Chip for Modeling the Human Blood-Brain Barrier and Regulation of Cellular Trafficking."
2023-06-30
[Bio TV] Get an inside look at the mind of CEO YongTae Kim!
2023-06-27
[2023 MPS World Summit] MEPSGEN's participation in 2023 MPS World Summit
2023-06-23
[CVB 2023] MEPSGEN's participation in CVB2023
2023-06-16
